You are here:
Publication details
Drug repositioning in genetically defined CLL cases reveals a potentional novel therapeutic use for approved drugs.
Authors | |
---|---|
Year of publication | 2021 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |